Summary Women with carcinoma in situ (CIS) of the cervix uteri, notified to the population-based Cancer Registry of the Swiss Canton of Vaud between 1974 and 1993, were actively followed up to 31 December 1993 for the occurrence of subsequent invasive neoplasms. Among 2190 incident cases of CIS, followed for a total of 22 225 person-years, 95 metachronous cancers were observed vs 77.9 expected, corresponding to a significant standardised incidence ratio (SIR) of 1.2. Ten cases of invasive cervical cancer were observed vs 3.0 expected (SIR = 3.4, P<0.01), the excess being larger in the first 10 years since CIS diagnosis. A total of 11 cases of four major tobacco-related sites (lung, mouth or pharynx, oesophagus and urinary bladder) were observed vs 5.1 expected, corresponding to a significant SIR of 2.2. The excess was observed > 10 years after CIS diagnosis. There was also an excess of non-melanomatous skin cancers (29 observed, 16.9 expected, SIR= 1.7; P <0.01), but not of skin melanoma and of any of the other neoplasms considered, including breast and corpus uteri. This population-based study, therefore, finds an excess of invasive cervical cancer in the short term after CIS diagnosis, and a medium-to long-term excess risk of tobacco-related and non-melanomatous skin neoplasms. These findings are discussed in terms of increased surveillance and case ascertainment after CIS, and of potential shared risk factors (tobacco and/or viral infections).
Women diagnosed with carcinoma in situ (CIS) of the cervix uteri constitute a selected population with reference to (1) their subsequent risk of invasive cervical cancer and (2) their incidence of other neoplasms, which may share risk factors with cervical carcinogenesis, or whose diagnosis may be influenced by the changed medical surveillance after CIS.
Only scattered data, however, are available on the issue. A study of cervical carcinoma in situ registered in Norway between 1970 (Bjorge et al., 1995 found no overall excess of cancer, but elevated rates for lung, oesophagus, nose, bladder and the urinary organs (i.e. major tobaccorelated neoplasms), vulva and vagina, and skin (squamous cell). Uterine cancer rates (cervix and corpus) were lower than expected. No excess risk of cutaneous melanoma was registered in a study of cervical intraepithelial neoplasia from Washington State (Schmulewitz et al., 1993) .
To provide further quantitative information on these open issues, we have linked data from 2190 women with in situ carcinoma of the cervix, registered by the Swiss Cancer Registry of Vaud between 1974 and 1993, with cancer incidence data from the same registry, with specific focus on cervical cancer, major tobacco-related neoplasms (since tobacco may influence cervical carcinogenesis; Winkelstein, 1990; Brinton, 1992) , skin cancer [which may be linked to viral infections (IARC, 1995) or influenced by detection accuracy], and, for comparative purposes, other cancer sites.
Materials and methods
Data for the present report were abstracted from the Vaud Cancer Registry file, which includes incident cases of malignant neoplasms in the canton (Levi et al., 1992) Since 1974, a registration scheme, applying the same standardised rules as for incident malignancies, has been implemented for carcinoma in situ and severe dysplasia of the uterine cervix (CIN III). All histological reports were scrutinised and reviewed when reporting a diagnosis of CIS.
After exclusion of all synchronous CIS and other cancers Calculation of expected numbers was based on site-, ageand calendar year-specific incidence rates, multiplied by the observed number of person-years at risk. The significance of the observed/expected ratios (standardised incidence ratio, SIR), and the corresponding 95% confidence interval (CI), was based on the exact Poisson distribution (Breslow and Day, 1987) . Table I gives the distribution of 2190 cases of CIS according to age, the corresponding incidence rate for the whole calendar period, and the person-years at risk in separate intervals of time since diagnosis, for a total of 22 225 person -years at risk. Table II gives the observed and expected numbers of all neoplasms and of selected cancer sites in separate strata of years since diagnosis. Overall, 95 metachronous cancers were observed vs 77.9 expected, corresponding to a significant SIR of 1.2. The excess was larger 15 years or more after CIS diagnosis (16 observed, 8.7 expected, SIR = 1.8). Ten cases of invasive cervical cancer were observed vs 3.0 expected (SIR=3.4), the excess incidence being largest in the first 5 years (six observed, one expected), and between 5 and 9 years (three observed, 0.9 expected) since CIS diagnosis, and levelling off thereafter.
Results
Four major tobacco-related sites (lung, mouth or pharynx, oesophagus and urinary bladder) were grouped together. A total of 11 cases (one of the mouth or pharynx, one of the oesophagus, seven of the lung, and two of the bladder) were observed, vs 5.1 expected, corresponding to a significant SIR of 2.2. The excess was greater 10 years or longer after CIS diagnosis (four observed, 1.4 expected, SIR= 2.9, between 10 and 14 years; five observed, 0.6 expected, SIR= 8.3, > 15 years). There was also an excess of non-melanomatous skin cancers (29 observed, 16.9 expected, SIR = 1.7), the elevated risk being greatest 5 years after CIS diagnosis or longer, but not of skin melanoma (three observed vs 3.2 expected, SIR = 0.9). None of the other neoplasms considered, including breast (SIR=0.8), corpus uteri (SIR= 1.4) or other miscellaneous sites (SIR= 0.8) showed excess incidence in women with CIS.
Discussion
In this population, there was an excess of invasive cervical cancer following histologically confirmed CIS, which was however restricted to the 10 years after CIS diagnosis. This may partly be due to increased ascertainment but underlines the importance of adequate treatment and surveillance of women after CIN (La Vecchia et al., 1995) .
There was also a significant excess of tobacco-related neoplasms, which became evident 10 years after CIS diagnosis. This may be interpretable in terms of shared risk factors, since a role of tobacco in cervical carcinogenesis has long been suspected (Winkelstein, 1977; Brinton, 1992) . In a review of 33 epidemiological studies of the relationship between cigarette smoking and cancer of the uterine cervix published over the last three decades (Winkelstein, 1990) , 26 found a direct association. This association has also been reported for cervical intraepithelial neoplasia (including CIN III; Parazzini et al., 1992 Parazzini et al., , 1996 Szarewski et al., 1996) . Furthermore, nicotine and cotinine have been identified in cervical mucus, and their concentration was directly related to cigarette smoking (Hellberg et al., 1988; Schiffman et al., 1987; McCann et al., 1992) .
A significant excess of lung cancer was also observed following invasive cervical cancer in the same population (Levi et al., 1993a) , and rates from several tobacco-related neoplasms were also elevated in a large study of in situ cervical cancer from Norway (Bjorge et al., 1995) . Likewise, an increase for lung and bladder cancer incidence was observed in Denmark (Storm and Ewertz, 1985; Storm, 1988) , and for lung, oral cavity, larynx and bladder in Connecticut following cervical cancer (Rabkin et al., 1992) .
It is also possible that human papilloma virus (HPV), the major identified risk factor for cervical neoplasms, is related to oral and pharyngeal, and, possibly, squamous cell carcinomas from other epithelia (IARC, 1995 The (non-melanomatous) skin cancer excess in the medium to long term following a CIS is more difficult to understand (although it has also been reported in other studies; Hartveit, 1988; Bjorge et al., 1995) . In this study, ascertainment bias is unlikely, since the excess risk became evident five or more years after CIS diagnosis. Again HPV (IARC, 1995) , or subtle immunological impairment, may be aspects shared by cervical and skin carcinogenesis. A confounding effect of some lifestyle habits, chiefly recreational sun exposure, cannot be excluded.
Among the strengths of the study, there are its population basis, which should render any estimate relatively free from selection bias (Levi et al., 1993b) and the complete histological confirmation of CIS cases. The absence of association with any of the other cancer sites is also reassuring with respect to surveillance bias, and provides relevant indications for the potential focus on a preventive and early diagnosis level for women diagnosed with CIS.
